LCA decisions in 2025 and through March 31, 2026
Regeneron Pharmaceuticals H-1B sponsor data for IT roles
Short answer
Regeneron Pharmaceuticals filed 34 H-1B labor condition applications for IT occupations in the DOL disclosure data (LCA decisions in 2025 and through March 31, 2026), which ranks it 384 of 3,365 employers with five or more IT filings. The most common occupation is computer and information systems managers (13 filings) and the most common state is NY (22).
Regeneron Pharmaceuticals filings by occupation
| Occupation | Filings | Share |
|---|---|---|
| Computer and Information Systems Managers | 13 | 38% |
| Information Technology Project Managers | 4 | 12% |
| Computer Systems Engineers/Architects | 4 | 12% |
| Computer Programmers | 3 | 9% |
Most common job titles
| Job title on the filing | Filings |
|---|---|
| Statistical Programmer | 3 |
| Director Product Management | 2 |
| Director It Operations Management | 2 |
| Associate Director | 2 |
| Principal It Applications Analyst | 2 |
| Principal Iops Data Engineer | 1 |
Wage levels and offered wage
| Wage level | Filings | Share |
|---|---|---|
| Level II | 12 | 35% |
| Level III | 5 | 15% |
| Level IV | 17 | 50% |
Most filings (50%) are at Level IV. The median offered wage on these filings is $185,712 a year against a median prevailing wage of $158,974, which is 11% above the prevailing wage. 100% of filings offer at least the prevailing wage listed on the same filing. 100% are full time. See prevailing wages by occupation and area for the DOL levels.
Employers filing in computer and information systems managers, like Regeneron Pharmaceuticals
| Employer | IT filings |
|---|---|
| Ccc Intelligent | 19 |
| Pwc | 62 |
| Northwell Health | 14 |
| Rsm | 13 |
| Takeda Pharmaceuticals | 11 |
| Valero | 11 |
About this data
Source and definitions are on the H-1B sponsors guide. An LCA is not an approval or a job opening. Corrections: support@matchwire.co.
Questions
How many H-1B filings did Regeneron Pharmaceuticals make for IT roles?
34 labor condition applications in this dataset (LCA decisions in 2025 and through March 31, 2026). By decision year: 2025: 6, 2026: 28.
What wage did Regeneron Pharmaceuticals offer on these filings?
The median offered wage was $185,712 a year against a median prevailing wage of $158,974, 11% above the prevailing wage.